View by Specialty

Headline News

View more

FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa

November 20, 2024
1 min read
Save

FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa

FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa

The FDA has approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults, UCB announced in a press release.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

AI in Medicine

23007715_AIinMedicineRC_OG

Artificial intelligence is a rapidly evolving field. Learn how and why it is being applied in clinical practice in multiple medical specialties.

View resource

Telehealth Resource Center

Healio Telehealth Resource Center

The pandemic has transformed health care. Keep up on the latest developments in telehealth and its impact on clinical practice.

View resource
View more Resources
View more Meeting News

Blogs & Columns

View more
Joel M. Gelfand

Beneath the Surface

with Joel M. Gelfand, MD, MSCE
An exploration of hot topics in dermatology.
View more Blogs & Columns